Timothy Wright, MD

Timothy M. Wright, MD, is a general partner with Time BioVentures. He previously served as chief R&D officer at Regulus Therapeutics, a clinical-stage biotech firm in San Diego. A native of Wilmington, Del., he earned his bachelor’s in biology at the University of Delaware and received his medical and research training at the Johns Hopkins University School of Medicine (rheumatology, immunology and molecular biology) and the Medical College of Virginia (internal medicine).

He held academic positions as a physician-scientist at Johns Hopkins and the University of Pittsburgh, where he was the chief of Rheumatology and Clinical Immunology and holder of the Margaret J. Miller Professorship for Arthritis Research before moving to the pharmaceutical industry in 2001.

Over the last 16 years, Wright has served in leadership positions from discovery research to late-stage pharmaceutical development at Pfizer (2001-2004), Novartis (2004-2015) and the California Institutes for Biomedical Research (Calibr, 2015-2016). In these roles, he has contributed to the development of numerous innovative medicines from concept to market.

He serves on the boards of Schrödinger and ENYO Pharma, and as a scientific advisor to several organizations, most notably the Bill and Melinda Gates Foundation.